Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
MeVis Medical Solutions AG is a company operating in the healthcare and medical imaging technology industry. Headquartered in Bremen, Germany, the company specializes in developing software solutions that support the interpretation of medical images for early and precise diagnosis. Its products are primarily used in the fields of radiology and digital health, providing tools that enhance analysis and communication for medical professionals. MeVis Medical’s strategic positioning is strengthened by its technological expertise in advanced image processing and its collaborations with major medical device manufacturers worldwide. The company's solutions aim to improve efficiency and accuracy in medical diagnostics.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
MeVis Medical Solutions AGEli Lilly
Last price
€19.75$1,427.28
Currency
EUR
USD
€36M$1.3T
26.0346.65
€0.76$30.81
-0.030.39
€0.95$6.69
4.80%0.48%
Sector
HealthHealth
Employees
12750,000
Ticker
€M3V$LLY
Primary listing
XETRANYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €M3V or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.